Report: Securities Lawsuits Against Life Sciences Firms Still On The Rise
Executive Summary
More investor suits were brought against life sciences companies in 2019 than in any of the past five years, according to a new report from law firm Dechert LLP. The increase continues a trend that has seen the number of such suits more than double since 2014.
You may also be interested in...
Lawyers: Securities Suits Among Life Sciences Firms Down In 2020 – But Don’t Expect Trend To Last
Attorneys with the law firm Dechert LLP expect the number of securities claims filed to rise in 2021 after a slide last year.
Survey Suggests 'New Normal' In Securities Suits Against Life Sciences Firms
A recent survey by law firm Dechert LLP found that 86 class action suits were filed against life sciences companies in 2018 – a slight drop from 2017, but still 350% higher than just a few years before.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.